Funded Tech Companies

Neuraltus Pharmaceuticals

Headquartered in Palo Alto, Neuraltus Pharmaceuticals has funding from private investors, Adams Street Partners and Latterell Venture Partners.

Company Overview

Company Name
Neuraltus Pharmaceuticals
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
2479 E. Bayshore Rd. 220
Palo Alto, CA 94303
USA
Email Address

Company Background Information

Overview
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders.
Profile
Neuraltus Pharmaceuticals LinkedIn Company Profile
Social Media
Neuraltus Pharmaceuticals Company Twitter Account
Company News
Neuraltus Pharmaceuticals News
Facebook
Neuraltus Pharmaceuticals on Facebook
YouTube
Neuraltus Pharmaceuticals on YouTube
Last Transaction
5/25/2016

Financing History

Date
Type
Amount
Venture Equity
$14,938,357
Venture Equity
$1,501,000
Venture Equity
$9,625,000
Venture Equity
$3,000,000
Venture Equity
$17,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
John Whelan
  John Whelan LinkedIn Profile  John Whelan Twitter Account  John Whelan News  John Whelan on Facebook
Chief Medical Officer
Gil Block
  Gil Block LinkedIn Profile  Gil Block Twitter Account  Gil Block News  Gil Block on Facebook
Chief Scientific Officer
Michael McGrath
  Michael McGrath LinkedIn Profile  Michael McGrath Twitter Account  Michael McGrath News  Michael McGrath on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Neuralitic Systems | Neuraly

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary